- Graduate School - University of Michigan Medical School (2001-2003)
- Fellowship - University of Illinois College of Medicine at Chicago (1996-1999), Gastroenterology
- Residency - Drexel University College of Medicine (1993-1996), Internal Medicine
- Medical School - Ponce School of Medicine (1989-1993)
Jorge Marrero, M.D.
Medical Director of Liver Transplantation, Associate Vice President, Clinical Transformation Officer
- Internal Medicine - Digestive & Liver Diseases
- Liver Transplant Evaluations
- Liver Transplant Medicine
Jorge Marrero, M.D., is Professor of Internal Medicine and Medical Director of the Liver Transplant Program at UT Southwestern Medical Center.
He is an expert in liver transplantation for patients with liver cancer (hepatocellular carcinoma). In addition to liver transplantation, he specializes in treating liver disease.
Dr. Marrero received his gastroenterology training at the University of Illinois at Chicago, where he discovered his interest in liver disease and liver transplantation.
His research focuses on how to detect early-stage liver cancer in patients with liver disease. He’s also involved in several treatment trials of new agents that are being evaluated for liver cancer.
Dr. Marrero is a founding member of the International Liver Cancer Association and a member of the American Association for the Study of Liver Disease, American College of Gastroenterology, American Gastroenterological Association, and the National Comprehensive Cancer Network’s Hepatobiliary Committee.
Dr. Marrero has lectured globally and written and reviewed numerous
research articles and book chapters for publications such as The New England Journal of Medicine, The Journal of the American Medical Association, the Journal of the National Cancer Institute, and the Journal of Clinical Oncology.
He was included in D Magazine's Best Doctors list for 2018.
Meet Dr. Marrero
Jorge Marrero, M.D., brings a family-style approach to care for patients with liver disease.
"We provide the best care in a personal fashion.”
Like his father, Dr. Marrero studied gastroenterology, but his path took him beyond general GI into his specialty of liver disease and liver transplantation. Because he specializes in both, he can guide patients who are very ill with advanced liver disease through transplantation to improved health.
As Medical Director of UT Southwestern's Liver Transplant Program, Dr. Marrero oversees all aspects of care when a patient comes in for a liver transplant, from initial evaluation to seeing a patient return safely home. His goal is to treat his patients like family.
“We want them to know that someone is acting in their best interests,” he says.
One of the reasons he chose to specialize in the study and treatment of the liver is that he can offer a solution when the liver fails: There’s hope for getting better.
Helping patients through a liver transplant provides Dr. Marrero with great satisfaction, as do the hugs he often receives from patients. He and his patients go through the transplant process together, and they celebrate together.
Diagnosing liver diseases requires significant expertise to properly interpret test results. Dr. Marrero has more than 15 years of experience in helping patients – and other doctors – understand the problems that occur with livers.
In addition to his work in the Liver Transplant Program, Dr. Marrero is involved in clinical research to improve early detection of liver cancer, and he participates in research for new treatments of the disease.
- American Gastroenterological Association (1999)
- American Association for the Study of Liver Disease (1999)
- Internal Liver Cancer Association (2006)
- Research Excellence in Gastroenterology and Liver Award 2003
- AW Research Excellence in Liver Cancer 2010
- Chair, Hepatobiliary Neoplasia Special Interest Group 2011, AASLD
- Best Doctors in America 2011
- Best Doctors in America 2005
Hepatocellular Carcinoma, 2nd ed.
Marrero JA(Ed.) (2009)
Primary Carcinomas of the Liver
Marrero JA, Hero K Hussain(Ed.) (2009)
Hepatology: A Textbook of Liver Disease
- Hepatocellular Carcinoma, 2nd ed.
Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L Hepatology (Baltimore, Md.) 2012 Feb 55 2 483-90
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009 Aug 15 8
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M Gastroenterology 2009 Jul 137 1 110-8
Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA Journal of magnetic resonance imaging : JMRI 2010 Aug 32 2 360-6
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
Singal AG, Conjeevaram HS, Volk ML, Fu S, Fontana RJ, Askari F, Su GL, Lok AS, Marrero JA Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 May 21 5 793-9
- Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
- Liver transplantation
- Hepatocellular carcinoma
- Liver Transplant Evaluations
- Liver Transplant Medicine
- Liver Disease
Q&A by Dr. Marrero
Articles by Dr. Marrero
Showing 2 locations
El Paso, Texas 79902